BG60544B1 - Antiviral and antibacterial preparation and method for its usage - Google Patents
Antiviral and antibacterial preparation and method for its usage Download PDFInfo
- Publication number
- BG60544B1 BG60544B1 BG91270A BG9127090A BG60544B1 BG 60544 B1 BG60544 B1 BG 60544B1 BG 91270 A BG91270 A BG 91270A BG 9127090 A BG9127090 A BG 9127090A BG 60544 B1 BG60544 B1 BG 60544B1
- Authority
- BG
- Bulgaria
- Prior art keywords
- dimer
- agent
- lysozyme
- ribonuclease
- administered
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17858888A | 1988-05-26 | 1988-05-26 | |
PCT/US1988/001785 WO1989011294A1 (en) | 1988-05-26 | 1988-05-26 | Antiviral or antibacterial compound and method of use |
OA59731A OA09785A (en) | 1988-05-26 | 1990-01-26 | Antiviral or antibacterial compound and method of use |
Publications (2)
Publication Number | Publication Date |
---|---|
BG91270A BG91270A (bg) | 1993-12-24 |
BG60544B1 true BG60544B1 (en) | 1995-08-28 |
Family
ID=33162813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG91270A BG60544B1 (en) | 1988-05-26 | 1990-02-22 | Antiviral and antibacterial preparation and method for its usage |
Country Status (23)
Country | Link |
---|---|
US (3) | US5200182A (da) |
EP (1) | EP0380484B1 (da) |
JP (1) | JPH0649659B2 (da) |
AT (1) | ATE93143T1 (da) |
AU (1) | AU624331B2 (da) |
BG (1) | BG60544B1 (da) |
CA (1) | CA1335425C (da) |
CS (1) | CS277030B6 (da) |
DK (1) | DK173078B1 (da) |
ES (1) | ES2011577A6 (da) |
FI (1) | FI900412A0 (da) |
HK (1) | HK42394A (da) |
HU (1) | HU204710B (da) |
IL (1) | IL90092A (da) |
LV (1) | LV10054B (da) |
MA (1) | MA21560A1 (da) |
MW (1) | MW390A1 (da) |
OA (1) | OA09785A (da) |
PH (1) | PH26284A (da) |
RU (1) | RU2092183C1 (da) |
WO (1) | WO1989011294A1 (da) |
YU (1) | YU109289A (da) |
ZA (1) | ZA893382B (da) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2092183C1 (ru) * | 1988-05-26 | 1997-10-10 | Ника Хелт Продактс Лимитед (Лихтенштейн) | Антивирусный или антибактериальный состав и способ его употребления |
US5989880A (en) * | 1990-01-08 | 1999-11-23 | Nika Health Products Ltd. | Method of preparing lysozyme dimers |
WO1991010730A1 (en) * | 1990-01-08 | 1991-07-25 | Nika Health Products Ltd. | Method of preparing ribonuclease dimers |
PL173978B1 (pl) * | 1992-07-13 | 1998-05-29 | Nika Health Products Ltd | Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej |
CH682541A5 (de) * | 1992-06-23 | 1993-10-15 | Urs Viktor Dr Wirth | Biochemische Inaktivierung von RNA-Viren. |
US6183742B1 (en) | 1992-07-13 | 2001-02-06 | Nika Health Products, Limited | Applications of lysozyme dimer |
DZ1964A1 (fr) * | 1995-01-13 | 2002-10-15 | Nika Health Products Ltd | Nouvelle applications d'un dimère de lysozyme. |
GB2304048A (en) * | 1995-08-12 | 1997-03-12 | John William Carson | Medicament containing saliva extract |
US6123937A (en) * | 1997-03-14 | 2000-09-26 | Nika Health Products, Limited | Applications of lysozyme dimer |
US7338936B2 (en) * | 2000-11-28 | 2008-03-04 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
US6716813B2 (en) * | 2000-11-28 | 2004-04-06 | House Ear Institute | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
JP2002187853A (ja) * | 2000-12-21 | 2002-07-05 | Shinei Ferumentekku:Kk | 動物の乳頭除菌剤および菌環境改善方法 |
DE10210285A1 (de) * | 2002-03-08 | 2003-11-13 | Medigene Ag | Reversibles Toxin und seine Verwendung |
WO2005115477A2 (en) | 2004-04-13 | 2005-12-08 | Quintessence Biosciences, Inc. | Non-natural ribonuclease conjugates as cytotoxic agents |
US20050244402A1 (en) * | 2004-04-30 | 2005-11-03 | Villanueva Julie M | Absorption of pain-causing agents |
US7348301B2 (en) * | 2006-02-16 | 2008-03-25 | Buckman Laboratories International, Inc. | Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems |
JP2009541333A (ja) * | 2006-06-23 | 2009-11-26 | クインテセンス バイオサイエンシーズ インコーポレーティッド | 修飾リボヌクレアーゼ |
EP2049151A4 (en) | 2006-07-17 | 2010-03-24 | Quintessence Biosciences Inc | METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER |
EP2134354A4 (en) * | 2007-03-02 | 2012-03-21 | Saint Simeon Lda | COMPOSITION AND METHOD FOR THE TREATMENT OF PAPILLOMA VIRUS AND HORSE SARCODES |
WO2009036000A2 (en) * | 2007-09-11 | 2009-03-19 | University Of Maryland, Baltimore | Methods of treating a microbial infection by modulating rnase-l expression and/or activity |
CA2702043A1 (en) * | 2007-10-08 | 2009-04-16 | Quintessence Biosciences, Inc. | Compositions and methods for ribonuclease-based therapies |
WO2010039985A1 (en) | 2008-10-01 | 2010-04-08 | Quintessence Biosciences, Inc. | Therapeutic Ribonucleases |
US20100215707A1 (en) * | 2009-02-25 | 2010-08-26 | Mcdonald Thomas | Activated creatinine and precursors thereof as antibacterial agents, compositions and products containing such agents and uses thereof |
NZ600269A (en) | 2009-05-20 | 2014-02-28 | Dec Int Nz Ltd | Delivery device for treatment of mastitis |
PL2457576T3 (pl) | 2010-11-29 | 2021-04-06 | Eurochit Danuta Kruszewska | Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji |
RU2548803C2 (ru) * | 2011-11-28 | 2015-04-20 | Общество с ограниченной ответственностью " Фарматренд" | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ |
RU2509801C2 (ru) * | 2012-03-22 | 2014-03-20 | Борис Михайлович Куриненко | СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius |
EP2674162A1 (en) | 2012-05-29 | 2013-12-18 | Danuta Kruszewska | Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same |
JP2015520773A (ja) | 2012-05-29 | 2015-07-23 | ダヌタ・クルセフスカDanutaKRUSZEWSKA | ヒトおよび動物における予防および医薬に有用であるラクトバチルス・ロイテリdan80を含むナノ製品ならびにこれらの医薬用途 |
RU2504397C1 (ru) * | 2012-10-25 | 2014-01-20 | Леонид Леонидович Клопотенко | Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия |
WO2014152678A1 (en) | 2013-03-15 | 2014-09-25 | University Of Massachusetts | Compositions and methods for delivering agents to the central nervous system |
US9573980B2 (en) | 2013-03-15 | 2017-02-21 | Spogen Biotech Inc. | Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots |
JP5806434B1 (ja) | 2014-02-21 | 2015-11-10 | 国立大学法人東京海洋大学 | ノロウィルス不活化剤及びその製造方法、ノロウィルス不活化方法、ノロウィルス不活化用リゾチーム類の製造方法、ノロウィルス感染の予防薬又は治療薬、並びにノロウィルス不活化用皮膚外用剤 |
KR20170038829A (ko) * | 2014-07-31 | 2017-04-07 | 큐피가부시키가이샤 | 함수 유동상 조성물 및 그 제조 방법, 그리고 리소자임 가공품 및/또는 그 염 그리고 그 제조 방법 |
BR122023020910A2 (pt) | 2014-09-17 | 2024-01-30 | Spogen Biotech Inc | Método para fornecimento de proteínas ou peptídeos a um animal |
LV15071B (lv) * | 2015-07-14 | 2016-02-20 | Rīgas Stradiņa Universitāte | Kompozīcija subklīniska mastīta ārstēšanai govīm |
RU2634264C1 (ru) * | 2016-09-19 | 2017-10-24 | Александр Ливиевич Ураков | Крем-молочко для лечения опоясывающего лишая |
CN113861760B (zh) | 2016-12-28 | 2023-05-05 | Dic株式会社 | 分散体 |
WO2021021765A1 (en) * | 2019-07-26 | 2021-02-04 | Evolve Biosystems, Inc. | Nutritive compositions with bioactive proteins |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1268M (fr) * | 1961-06-29 | 1962-04-24 | Puiseux | Médicament antimitotique et antiviral. |
FR4020M (da) * | 1965-01-29 | 1966-03-21 | ||
DE1517751C3 (de) * | 1965-07-08 | 1975-02-27 | Eisai Co., Ltd., Tokio | Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten |
DE1545644A1 (de) * | 1965-12-06 | 1969-08-07 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen |
GB1110504A (en) * | 1966-03-18 | 1968-04-18 | Prodotti Antibiotici Spa | Pharmaceutical compositions |
US4221794A (en) * | 1979-06-21 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | Method of imparting immunomodulating and antiviral activity |
US4510144A (en) * | 1981-08-26 | 1985-04-09 | Newport Pharmaceuticals International | Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives |
EP0187705A3 (en) * | 1985-01-08 | 1988-05-11 | Norwich Eaton Pharmaceuticals, Inc. | Imidazo(4,5-f)quinolines useful as immunomodulating agents |
US4739046A (en) * | 1985-08-19 | 1988-04-19 | Luzio Nicholas R Di | Soluble phosphorylated glucan |
US4744984A (en) * | 1985-10-08 | 1988-05-17 | Vetrepharm Research, Inc. | Antiviral immunotherapeutic agent and preparation thereof |
RU2092183C1 (ru) * | 1988-05-26 | 1997-10-10 | Ника Хелт Продактс Лимитед (Лихтенштейн) | Антивирусный или антибактериальный состав и способ его употребления |
-
1988
- 1988-05-26 RU SU884743095A patent/RU2092183C1/ru active
- 1988-05-26 AU AU19408/88A patent/AU624331B2/en not_active Expired
- 1988-05-26 WO PCT/US1988/001785 patent/WO1989011294A1/en active IP Right Grant
- 1988-05-26 JP JP63504463A patent/JPH0649659B2/ja not_active Expired - Fee Related
- 1988-05-26 AT AT88905146T patent/ATE93143T1/de not_active IP Right Cessation
- 1988-05-26 US US07/459,738 patent/US5200182A/en not_active Expired - Lifetime
- 1988-05-26 HU HU883981A patent/HU204710B/hu unknown
- 1988-05-26 EP EP88905146A patent/EP0380484B1/en not_active Expired - Lifetime
-
1989
- 1989-04-20 CA CA000597341A patent/CA1335425C/en not_active Expired - Fee Related
- 1989-04-27 IL IL9009289A patent/IL90092A/en not_active IP Right Cessation
- 1989-05-08 ZA ZA893382A patent/ZA893382B/xx unknown
- 1989-05-16 ES ES8901637A patent/ES2011577A6/es not_active Expired - Fee Related
- 1989-05-23 PH PH38684A patent/PH26284A/en unknown
- 1989-05-24 MA MA21811A patent/MA21560A1/fr unknown
- 1989-05-26 YU YU01092/89A patent/YU109289A/xx unknown
- 1989-05-26 CS CS893180A patent/CS277030B6/cs not_active IP Right Cessation
-
1990
- 1990-01-22 MW MW3/90A patent/MW390A1/xx unknown
- 1990-01-22 DK DK199000168A patent/DK173078B1/da not_active IP Right Cessation
- 1990-01-25 FI FI900412A patent/FI900412A0/fi not_active IP Right Cessation
- 1990-01-26 OA OA59731A patent/OA09785A/en unknown
- 1990-02-22 BG BG91270A patent/BG60544B1/bg unknown
-
1992
- 1992-04-08 US US07/865,002 patent/US5466449A/en not_active Expired - Lifetime
- 1992-12-28 LV LVP-92-508A patent/LV10054B/en unknown
-
1994
- 1994-05-05 HK HK42394A patent/HK42394A/xx not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/474,663 patent/US6099835A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU1940888A (en) | 1989-12-12 |
CS277030B6 (en) | 1992-11-18 |
JPH03504121A (ja) | 1991-09-12 |
DK16890D0 (da) | 1990-01-22 |
US6099835A (en) | 2000-08-08 |
HK42394A (en) | 1994-05-13 |
CS318089A3 (en) | 1992-05-13 |
PH26284A (en) | 1992-04-10 |
FI900412A0 (fi) | 1990-01-25 |
IL90092A (en) | 1995-03-30 |
EP0380484A1 (en) | 1990-08-08 |
LV10054B (en) | 1995-02-20 |
DK173078B1 (da) | 1999-12-20 |
OA09785A (en) | 1994-04-15 |
ATE93143T1 (de) | 1993-09-15 |
WO1989011294A1 (en) | 1989-11-30 |
RU2092183C1 (ru) | 1997-10-10 |
HUT54060A (en) | 1991-01-28 |
US5466449A (en) | 1995-11-14 |
LV10054A (lv) | 1994-05-10 |
ZA893382B (en) | 1991-01-30 |
MA21560A1 (fr) | 1989-12-31 |
MW390A1 (en) | 1990-11-14 |
ES2011577A6 (es) | 1990-01-16 |
YU109289A (en) | 1991-08-31 |
HU883981D0 (en) | 1990-12-28 |
JPH0649659B2 (ja) | 1994-06-29 |
EP0380484B1 (en) | 1993-08-18 |
HU204710B (en) | 1992-02-28 |
DK16890A (da) | 1990-01-22 |
US5200182A (en) | 1993-04-06 |
BG91270A (bg) | 1993-12-24 |
AU624331B2 (en) | 1992-06-11 |
CA1335425C (en) | 1995-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG60544B1 (en) | Antiviral and antibacterial preparation and method for its usage | |
Spink et al. | Sulfathiazole: clinical evaluation | |
RU2145875C1 (ru) | Применение димера лизоцима в качестве лекарственного средства и содержащие его композиции | |
AP628A (en) | New applications of lysozyme dimer. | |
US20220380744A1 (en) | Method of treating infections by bacteriolytic enzymes and manufacture thereof | |
EP0343631A2 (en) | Preventing agent for human immunodeficiency virus infection comprising menfegol | |
CN100388949C (zh) | 一种用于防治牛子***的溶葡萄球菌酶冻干粉剂 | |
HUT63335A (en) | Process for producing pharmaceutical compositions for treating diseases of mammals | |
KR930004599B1 (ko) | 항바이러스성 또는 항균성 조성물 | |
DE3883392T2 (de) | Verwendung eines Lysozymdimeren und/oder Ribonucleasedimeren zur Herstellung eines antiviralen oder antibakteriellen Arzneimittels. | |
JOHNSON | Dermatologic evaluation of yeast, tyrothricin, chlorophyll and nitrofurazone | |
RO110037B1 (ro) | Compoziții antivirale sau antibacteriene și metodă de tratare a infecțiilor, cu acestea | |
Keyserlinq et al. | 1120 PREVALENCE OF GENITAL HERPES AND/OR HERPES SIMPLEX VIRUS TYPE 2 (HSV-2) ANTIBODIES IN TWO OBSTETRIC POPULATIONS | |
JP2006521298A (ja) | 物理的又は化学的因子により生じる非特異的炎症の治療及び抑制におけるn‐アセチル‐d‐グルコサミンの使用 | |
JPH0158167B2 (da) | ||
Johnson et al. | 1117 STAPHYLOCOCCUS EPIDERMIDIS SLIME INTERFERES WITH NEUTROPHIL PHAGOCYTOSIS AND OXIDATIVE KILLING MECHANISMS | |
MXPA97005246A (en) | New applications of dimero de lisoz | |
MXPA97001730A (es) | Vacuna enteral para infecciones vaginales |